Massive Real-World study tracks heart benefits of kidney drug
NCT ID NCT06608212
First seen Nov 01, 2025 · Last updated May 15, 2026 · Updated 31 times
Summary
This study looks at real-world data from 150,000 people with chronic kidney disease and type 2 diabetes to see how safe and effective the drug finerenone is in routine medical care. Researchers will compare heart problems like heart attacks and hospitalizations for heart failure between those taking finerenone and those not taking it. No extra visits or tests are needed—only existing electronic health records are used.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES MELLITUS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Bayer
Whippany, New Jersey, 07981, United States
Conditions
Explore the condition pages connected to this study.